arrow
M

Matteo Dragani

University of Turin
H指数:10
被引数:398

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Tyrosine kinase inhibitor discontinuation in non-allografted Philadelphia-positive acute lymphoblastic leukemia patients: a Campus ALL real-life study

酪氨酸激酶抑制剂停药在非异基因移植费城染色体阳性急性淋巴细胞白血病患者中的应用:一项Campus ALL真实世界研究

2025-01-090
OA
Diagnostic capabilities, clinical features, and longitudinal UBA1 clonal dynamics of a nationwide VEXAS cohort
2023-12-1814
OAAI
Efficacy and safety of nilotinib as frontline treatment in elderly (> 65 years) chronic myeloid leukemia patients outside clinical trials

尼洛替尼作为一线治疗老年 (> 65岁) 慢性粒细胞白血病患者的疗效和安全性

2023-04-206
OAAI
Allogeneic transplantation in acute myelogenous leukemia: a comprehensive single institution's experience
2023-03-230
OAAI
Sequence analyses of relapsed or refractory diffuse large B-cell lymphomas unravel three genetic subgroups of patients and the GNA13 mutant as poor prognostic biomarker, results of LNH-EP1 study
2023-01-181
OAAI
A Retrospective Analysis about Frequency of Monitoring in Italian Chronic Myeloid Leukemia Patients after Discontinuation
2020-11-173
OAAI
Iron overload alters the energy metabolism in patients with myelodysplastic syndromes: results from the multicenter FISM BIOFER study
2020-06-0813
OAAI
Observational study of chronic myeloid leukemia Italian patients who discontinued tyrosine kinase inhibitors in clinical practice
2019-02-2860
OAAI